Medazepam

Summary

Medazepam is a drug that is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It is known by the following brand names: Azepamid, Nobrium, Tranquirax (mixed with bevonium), Rudotel, Raporan, Ansilan and Mezapam.[2] Medazepam is a long-acting benzodiazepine drug. The half-life of medazepam is 36–200 hours.[3]

Medazepam
Clinical data
Trade namesRudotel
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability50–75% (Сmax = 1–2 hours)
Protein binding>99%
MetabolismHepatic
Elimination half-life2 hours, 36–150 hours (terminal)
ExcretionRenal (63–85%), Biliary 15–37%
Identifiers
  • 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine
CAS Number
  • 2898-12-6 ☒N
PubChem CID
  • 4041
DrugBank
  • none ☒N
ChemSpider
  • 3901 checkY
UNII
  • P0J3387W3S
KEGG
  • D01292 checkY
ChEMBL
  • ChEMBL28333 checkY
CompTox Dashboard (EPA)
  • DTXSID1048708 Edit this at Wikidata
ECHA InfoCard100.018.895 Edit this at Wikidata
Chemical and physical data
FormulaC16H15ClN2
Molar mass270.76 g·mol−1
3D model (JSmol)
  • Interactive image
  • ClC1=CC(C(C2=CC=CC=C2)=NCCN3C)=C3C=C1
  • InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3 checkY
  • Key:YLCXGBZIZBEVPZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pharmacology edit

Medazepam acts as a prodrug to Nordazepam. Benzodiazepine drugs including medazepam increase the inhibitory processes in the cerebral cortex by allosteric modulation of the GABA receptor.[4] Benzodiazepines may also act via micromolar benzodiazepine-binding sites as Ca2+ channel blockers and significantly inhibited depolarization-sensitive calcium uptake in experiments with cell components from rat brains. This has been conjectured as a mechanism for high dose effects against seizures in a study.[5] It has major active benzodiazepine metabolites, which gives it a more prolonged therapeutic effect after administration.[6]

See also edit

References edit

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ "Benzodiazepines". Encyclopedia of Drugs.
  3. ^ Ashton H (April 2007). "Benzodiazepine Equivalency Table". Benzodiazepines Co-operation Not Confrontation (BCNC). Archived from the original on September 28, 2007. Retrieved September 23, 2007.
  4. ^ Zakusov VV, Ostrovskaya RU, Kozhechkin SN, Markovich VV, Molodavkin GM, Voronina TA (October 1977). "Further evidence for GABA-ergic mechanisms in the action of benzodiazepines". Archives Internationales de Pharmacodynamie et de Therapie. 229 (2): 313–26. PMID 23084.
  5. ^ Taft WC, DeLorenzo RJ (May 1984). "Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations" (PDF). Proceedings of the National Academy of Sciences of the United States of America (PDF). 81 (10): 3118–22. Bibcode:1984PNAS...81.3118T. doi:10.1073/pnas.81.10.3118. PMC 345232. PMID 6328498.
  6. ^ Jochemsen R, Breimer DD (1984). "Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles". Current Medical Research and Opinion. 8 Suppl 4: 60–79. doi:10.1185/03007998409109545. PMID 6144464.

External links edit

  • Inchem - Medazepam